Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
Go back to Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine| Pfizer Inc. (NYSE: PFE) | Delayed: 29.77 -0.34 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.11 | 52 Week High | $37.39 | |||
| Open | $30.00 | 52 Week Low | $28.25 | |||
| Day High | $30.09 | P/E | 18.04 | |||
| Day Low | $29.72 | EPS | $1.65 | |||
| Volume | 6,844,643 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 29.77 -0.34 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.11 | 52 Week High | $37.39 | |||
| Open | $30.00 | 52 Week Low | $28.25 | |||
| Day High | $30.09 | P/E | 18.04 | |||
| Day Low | $29.72 | EPS | $1.65 | |||
| Volume | 6,844,643 | |||||



